Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Guggenheim Healthcare 2nd Annual Neuro/Immunology Day onMonday, November 16, 2020 - Stifel 2020
Virtual Healthcare Conference onTuesday, November 17, 2020 at4:40 pm ET Jefferies Virtual London Healthcare Conference onThursday, November 19, 2020 at9:40 am ET (2:40 pm GMT )
The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at www.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days.
About
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of
Investor/Media Contact:
Phone: 604.484.3353
Email: investors@xenon-pharma.com
Source: Xenon Pharmaceuticals Inc.